A total of 88 patients were enrolled in a double-blind comparison of cefaclor and amoxicillin-clavulanic acid for the outpatient treatment of soft tissue infections (abscesses, cellulitis, and impetigo). In 84 clinically evaluable patients, high cure rates were obtained for all treatment groups (64 to 85%). Patients who received amoxicillin-clavulanic acid had a much higher incidence of gastrointestinal side effects than did patients who received cefaclor (34 versus 3%, P < 0.005). However, only five patients with gastrointestinal reactions to amoxicillin-clavulanic acid had symptoms severe enough to warrrant halting the completion of antibiotic therapy.
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Clavulanic acid is a potent inhibitor of staphylococcal beta-lactamases, as well as some betalactamases of gram-negative aerobic and anaerobic bacteria (18) . Clavulanic acid has been recently combined with amoxicillin in two different dosage preparations (Augmentin; Beecham Laboratories). Both CO2 at 35°C for 48 h, and the thioglycolate tubes were incubated at 35C for 7 days. Antibiotic treatment was continued for a minimum of 5 days and for 2 to 3 days beyond the time when the infection was cured (maximum, 10 days), except that all streptococcal infections were treated for 10 days. A patient was considered clinically cured if the skin infection was healed at the time the drug was discontinued. If the skin infection had subsided to less than half of its initial size, the patient was considered clinically improved. Statistical differences between treatment groups were analyzed by the chi-square test. Antibiotic susceptibility testing was performed by the agar overlay diffusion method (3), using antibiotic disks containing cephalothin (30 mg), oxacillin ( The main difference between antibiotic treatment groups in this study was the incidence of adverse effects. Over 40% of patients who received A+C had side effects regardless of dosage, whereas only 7% of the CEF-treated patients suffered any untoward effects (P < 0.005). This low rate of CEF side effects-was similar to rates given in previously published CEF studies (6, 8) . Amoxicillin alone has been reported to have an adverse side effect rate of 5 to 6% (12) . Double-blind studies comparing CEF and amoxicillin in adults have shown a similar incidence of adverse effects (4, 9) . The high rate of gastrointestinal reactions in this study (34% of all A+C-treated patients) agrees with the results of Watson and Mahendra, who reported that 156 of 482 patients treated with A+C had side effects (32% of patients), including 15% with diarrhea, 6% with nausea or vomiting, and 2% with rash (17) . Stamboulian et al. found that the addition of clavulanic acid to amoxicillin caused more nausea than did amoxicillin alone (14) . Staniforth et al. demonstrated that nausea may be reduced by taking A+C with food, without affecting bioavailability (15) .
In this trial, most side effects were mild and well tolerated. Only 5 of 18 A+C patients discontinued their medication because of intolerance, as compared with 1 of 3 CEF patients.
Both antibiotics were very efficacious for the treatment of outpatient skin and soft tissue infections. Therefore, the choice between these antibiotics may be dependent upon drug cost and other differences not measured in this comparative study.
